RxDoctor Payments Data

William Will, MD

Internal Medicine · Tinley Park, ILNPI 1568471860

Payments from drug & device makers

$7,291in general payments, 2019–2025

Across 394 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$851
  • AstraZeneca$748
  • Lilly USA, LLC$677
  • Boehringer Ingelheim$664
  • Novo Nordisk$659
  • Bayer$590
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$7,284100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,291 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$196,296
Medicare patients
423
Services billed
4,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$92,029
JardianceEmpagliflozin54$78,200
OzempicSemaglutide28$54,296
TrulicityDulaglutide12$34,748
FarxigaDapagliflozin Propanediol14$13,467
Breo ElliptaFluticasone/Vilanterol13$5,585
Atorvastatin Calcium509$4,499
Levothyroxine Sodium264$3,403
Desvenlafaxine Succinate ErDesvenlafaxine Succinate26$2,553
Rosuvastatin Calcium196$2,132
Metoprolol Succinate118$1,981
Lisinopril265$1,918
Amlodipine Besylate267$1,823
Pravastatin Sodium117$1,558
Memantine Hcl ErMemantine Hcl26$1,550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$574$92,02976 claims
Boehringer IngelheimJardiance$664$78,20054 claims
Novo NordiskOzempic$659$54,29628 claims
Lilly USA, LLCTrulicity$677$34,74812 claims
AstraZenecaFarxiga$748$13,46714 claims
GSKBreo Ellipta$101$5,58513 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$18$3,403264 claims
AbbVieSynthroid$851$1,24219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Tinley Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →